Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BFS

Saul Centers Inc

Jun 01 • 02:33PM ET

34.58

-0.08 -0.24 %

Real Estate • REIT - Retail • USA • Small • NYSE

Peers: AKR KRG FRT KIM REG UE PECO BRX AAT ALX

| Held by: IJR VNQ VTI VB IWM VBR VXF SPSM IWO XSLV

Index	RUT	P/E	32.78	EPS (ttm)	1.05	Insider Own	46.44%	Shs Outstand	24.60M	Perf Week	0.13%
Market Cap	848.33M	Forward P/E	43.22	EPS next Y	0.80	Insider Trans	0.03%	Shs Float	13.14M	Perf Month	0.42%
Enterprise Value	2.79B	PEG	-	EPS next Q	0.14	Inst Own	46.84%	Short Float	2.54%	Perf Quarter	1.01%
Income	25.64M	P/S	2.85	EPS this Y	-47.71%	Inst Trans	2.28%	Short Ratio	5.70	Perf Half Y	11.07%
Sales	297.75M	P/B	7.28	EPS next Y	40.35%	ROA	1.72%	Short Interest	0.33M	Perf YTD	9.66%
Book/sh	4.75	P/C	90.92	EPS next 5Y	-1.55%	ROE	11.69%	52W High	35.75 -3.29%	Perf Year	2.66%
Cash/sh	0.38	P/FCF	8.59	EPS past 3/5Y	-12.61% -2.77%	ROIC	2.11%	52W Low	29.16 18.57%	Perf 3Y	1.45%
Dividend Est.	-	EV/EBITDA	15.36	Sales past 3/5Y	5.86% 4.81%	Gross Margin	50.58%	Volatility	1.66% 2.12%	Perf 5Y	-22.30%
Dividend TTM	2.36 (6.83%)	EV/Sales	9.38	EPS Y/Y TTM	-28.42%	Oper. Margin	40.89%	ATR (14)	0.73	Perf 10Y	-38.02%
Dividend Ex-Date	Apr 15, 2026	Quick Ratio	0.40	Sales Y/Y TTM	8.31%	Profit Margin	8.61%	RSI (14)	54.57	Recom	1.00
Dividend Gr. 3/5Y	0.28% 2.17%	Current Ratio	0.40	EPS Q/Q	-10.33%	SMA20	0.95%	Beta	0.90	Target Price	40.00
Payout	217.35%	Debt/Eq	5.30	Sales Q/Q	8.56%	SMA50	2.17%	Rel Volume	0.83	Prev Close	34.66
Employees	156	LT Debt/Eq	4.80	Earnings	May 07 AMC	SMA200	6.45%	Avg Volume	58.65K	Price	34.58
IPO	Aug 19, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 2.28%	Trades		Volume	38,837	Change	-0.24%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-11-24	Resumed	B. Riley Securities	Buy	$43.50
Jan-04-23	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-09-22	Downgrade	B. Riley Securities	Buy → Neutral	$53
Apr-23-21	Initiated	Raymond James	Outperform	$46
Mar-04-21	Upgrade	B. Riley Securities	Neutral → Buy	$32 → $50
Jan-29-20	Downgrade	CapitalOne	Overweight → Equal Weight
Apr-05-18	Initiated	B. Riley FBR, Inc.	Neutral	$54
Jan-06-14	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-25-13	Upgrade	Robert W. Baird	Neutral → Outperform	$46 → $48
Sep-14-12	Downgrade	Robert W. Baird	Outperform → Neutral	$44 → $46
Oct-01-09	Upgrade	Keefe Bruyette	Underperform → Mkt Perform
Jul-14-08	Reiterated	Robert W. Baird	Neutral	$61 → $58
Dec-11-07	Downgrade	Keefe Bruyette	Mkt Perform → Underperform
Oct-15-07	Downgrade	Robert W. Baird	Outperform → Neutral	$58 → $61
Oct-11-07	Downgrade	Ferris Baker Watts	Buy → Neutral
Oct-04-07	Reiterated	Ferris Baker Watts	Buy	$52 → $56
Jun-21-07	Upgrade	Ferris Baker Watts	Neutral → Buy	$52
Feb-23-07	Upgrade	Robert W. Baird	Neutral → Outperform	$55 → $64
Feb-23-07	Reiterated	Ryan, Beck & Co	Mkt Perform	$44 → $50

Show Previous Ratings

May-07-26 05:01PM	Saul Centers: Q1 Earnings Snapshot (Associated Press)
04:14PM	Saul Centers, Inc. Reports First Quarter 2026 Earnings (PR Newswire)
Mar-16-26 04:23PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Feb-27-26 04:26PM	Saul Centers: Q4 Earnings Snapshot (Associated Press Finance)
04:09PM	Saul Centers, Inc. Reports Fourth Quarter and Full Year 2025 Earnings (PR Newswire)
06:10PM	Loading…
Jan-21-26 06:10PM	Saul Centers, Inc. Announces Tax Treatment of 2025 Dividends (PR Newswire)
Dec-04-25 04:05PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Nov-06-25 05:19PM	Saul Centers: Q3 Earnings Snapshot (Associated Press Finance)
04:11PM	Saul Centers, Inc. Reports Third Quarter 2025 Earnings (PR Newswire)
Sep-23-25 05:16PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Aug-07-25 04:22PM	Saul Centers: Q2 Earnings Snapshot (Associated Press Finance)
04:08PM	Saul Centers, Inc. Reports Second Quarter 2025 Earnings (PR Newswire)
Jun-12-25 04:05PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
May-08-25 06:15PM	Saul Centers (BFS) Q1 FFO Miss Estimates (Zacks)
05:13PM	Saul Centers: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Loading…
04:08PM	Saul Centers, Inc. Reports First Quarter 2025 Earnings (PR Newswire)
Apr-29-25 05:55PM	Kite Realty Group (KRG) Beats Q1 FFO and Revenue Estimates (Zacks)
Apr-11-25 03:45PM	Disparate Property Supply In Tampa Creates Selective Opportunity (Seeking Alpha)
Apr-10-25 09:59AM	Urban Edge Properties (UE) Moves 7.8% Higher: Will This Strength Last? (Zacks)
Apr-07-25 07:30AM	Mousetraps: 9 High-Yield REITS With Potentially Unsafe Dividends (Seeking Alpha)
Mar-24-25 05:59PM	Saul Centers (BFS): Among Top Dividend Stocks that Pay More than the US Average Rental Yield (Insider Monkey)
Mar-06-25 04:22PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Feb-28-25 06:35PM	Saul Centers (BFS) Q4 FFO and Revenues Lag Estimates (Zacks)
05:38PM	Saul Centers: Q4 Earnings Snapshot (Associated Press Finance)
05:21PM	Saul Centers, Inc. Reports Fourth Quarter 2024 Earnings (PR Newswire)
Jan-23-25 10:35AM	Saul Centers, Inc. Announces Tax Treatment of 2024 Dividends (PR Newswire)
Dec-19-24 12:00PM	What Makes Saul Centers (BFS) a New Buy Stock (Zacks)
Dec-05-24 04:33PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Nov-07-24 05:50PM	Saul Centers (BFS) Q3 FFO and Revenues Beat Estimates (Zacks)
04:47PM	Saul Centers: Q3 Earnings Snapshot (Associated Press Finance)
04:13PM	Loading…
04:13PM	Saul Centers, Inc. Reports Third Quarter 2024 Earnings (PR Newswire)
Oct-19-24 07:00PM	If You Invested $1,000 In Saul Centers Stock 20 Years Ago, How Much Would You Have Now (Benzinga)
Oct-16-24 08:50AM	Saul Centers (BFS) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Sep-25-24 08:50AM	Here's Why Momentum in Saul Centers (BFS) Should Keep going (Zacks)
Sep-19-24 04:35PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Sep-09-24 08:50AM	Here's What Could Help Saul Centers (BFS) Maintain Its Recent Price Strength (Zacks)
Aug-23-24 08:50AM	What Makes Saul Centers (BFS) a Good Fit for 'Trend Investing' (Zacks)
Aug-09-24 06:00AM	3 Best-Value REITs To Buy In August (Benzinga)
Aug-04-24 10:00AM	3 Top Retail REITs for High Yields and Dividend Growth (Benzinga)
Aug-01-24 06:10PM	Saul Centers (BFS) Beats Q2 FFO and Revenue Estimates (Zacks)
05:11PM	Saul Centers: Q2 Earnings Snapshot (Associated Press Finance)
04:12PM	Saul Centers, Inc. Reports Second Quarter 2024 Earnings (PR Newswire)
Jun-20-24 04:27PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
May-03-24 01:36PM	Saul Centers Shares Decline Following Q1 Results (MT Newswires)
May-02-24 10:53PM	BFS Stock Earnings: Saul Centers Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:15PM	Saul Centers Inc (BFS) Earnings Exceed Analyst Projections in Q1 2024 (GuruFocus.com)
05:13PM	Saul Centers: Q1 Earnings Snapshot (Associated Press Finance)
04:46PM	Saul Centers, Inc. Reports First Quarter 2024 Earnings (PR Newswire)
Apr-20-24 11:00AM	3 Stocks CEOs Are Buying Heading Into May 2024 (InvestorPlace)
Mar-14-24 04:17PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Mar-05-24 11:29AM	2 Retail REITs With Yields Up to 6.4% (Benzinga)
Feb-29-24 04:53PM	Saul Centers Inc (BFS) Reports Revenue and Net Income Growth in Q4 2023 (GuruFocus.com)
04:11PM	Saul Centers, Inc. Reports Fourth Quarter 2023 Earnings (PR Newswire)
Jan-19-24 01:30PM	Saul Centers, Inc. Announces Tax Treatment of 2023 Dividends (PR Newswire)
Jan-12-24 05:08AM	Saul Centers Inc's Dividend Analysis (GuruFocus.com)
Dec-07-23 04:36PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Nov-04-23 05:46AM	Saul Centers Inc (BFS) Reports 4.4% Increase in Total Revenue for Q3 2023 (GuruFocus.com)
Nov-02-23 05:55PM	Saul Centers: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	Saul Centers, Inc. Reports Third Quarter 2023 Earnings (PR Newswire)
Oct-13-23 07:08AM	Saul Centers Inc's Dividend Analysis (GuruFocus.com)
Sep-21-23 04:05PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Buyers & Sellers for 08/11/2023 (Argus Research)
Aug-03-23 07:25PM	Saul Centers (BFS) Q2 FFO and Revenues Top Estimates (Zacks)
06:23PM	Saul Centers: Q2 Earnings Snapshot (Associated Press Finance)
04:18PM	Saul Centers, Inc. Reports Second Quarter 2023 Earnings (PR Newswire)
Aug-02-23 06:35PM	Equinix (EQIX) Q2 FFO and Revenues Beat Estimates (Zacks)
Jul-25-23 07:45AM	SITE CENTERS CORP. (SITC) Tops Q2 FFO and Revenue Estimates (Zacks)
Jun-22-23 04:21PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Jun-21-23 08:00PM	BFS: Lowering target price to $40.00 (Argus Research)
Jun-02-23 05:00AM	Zacks Industry Outlook Highlights Acadia Realty and Saul Centers (Zacks)
Jun-01-23 10:58AM	2 Top REITs to Buy From a Prospering Retail REIT Industry (Zacks)
May-29-23 09:55AM	Bears are Losing Control Over Saul Centers (BFS), Here's Why It's a 'Buy' Now (Zacks)
May-24-23 11:48AM	Simon (SPG) Partners With The Webster to Revamp Luxury Shopping (Zacks)
May-22-23 12:43PM	Regency (REG) Bolsters NY Presence With SunVet Mall Revamp (Zacks)
May-19-23 12:24PM	Regency Centers (REG) to Acquire Urstadt Biddle in a $1.4B Deal (Zacks)
May-12-23 06:52AM	Daily Vickers Top Buyers & Sellers for 05/12/2023 (Argus Research)
May-04-23 07:05PM	Saul Centers (BFS) Tops Q1 FFO Estimates (Zacks)
06:11PM	Saul Centers: Q1 Earnings Snapshot (AP Finance)
04:10PM	Saul Centers, Inc. Reports First Quarter 2023 Earnings (PR Newswire)
Apr-26-23 08:00PM	BFS: Lowering target price to $39.00 (Argus Research)
Mar-15-23 06:04AM	Great news for Saul Centers, Inc. (NYSE:BFS): Insiders acquired stock in large numbers last year (Simply Wall St.)
Mar-09-23 04:05PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Mar-02-23 07:55PM	Saul Centers (BFS) Lags Q4 FFO Estimates (Zacks)
06:52PM	Saul Centers: Q4 Earnings Snapshot (AP Finance)
04:49PM	Saul Centers, Inc. Reports Fourth Quarter 2022 Earnings (PR Newswire)
Feb-22-23 07:45PM	EPR Properties (EPR) Tops Q4 FFO and Revenue Estimates (Zacks)
Feb-21-23 05:55PM	Tanger Factory Outlet (SKT) Beats Q4 FFO and Revenue Estimates (Zacks)
Jan-30-23 02:59PM	Saul REIT moves to update industrial zoning on parcels owned in Sterling, hasn't said for what use (American City Business Journals)
02:59PM	Saul Centers moves to update industrial zoning on parcels owned in Sterling, hasn't said for what use (American City Business Journals)
Jan-26-23 03:11PM	Saul REIT moves to redevelop downtown Bethesda site near Marriott HQ (American City Business Journals)
03:11PM	Saul Centers moves to redevelop downtown Bethesda site near Marriott HQ (American City Business Journals)
Jan-19-23 04:05PM	Saul Centers, Inc. Announces Tax Treatment of 2022 Dividends (PR Newswire)
Dec-14-22 11:28AM	Boasting A 12% Return On Equity, Is Saul Centers, Inc. (NYSE:BFS) A Top Quality Stock? (Simply Wall St.)
Dec-09-22 04:11PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Nov-08-22 07:15PM	Saul Centers (BFS) Q3 FFO Miss Estimates (Zacks)
04:46PM	Saul Centers, Inc. Reports Third Quarter 2022 Earnings (PR Newswire)
Oct-06-22 03:48PM	The past five years for Saul Centers (NYSE:BFS) investors has not been profitable (Simply Wall St.)
Sep-22-22 04:21PM	Saul Centers Declares Quarterly Dividends (PR Newswire)
Aug-04-22 06:35PM	Saul Centers (BFS) Q2 FFO and Revenues Lag Estimates (Zacks)
04:14PM	Saul Centers, Inc. Reports Second Quarter 2022 Earnings (PR Newswire)

Saul Centers, Inc. is a real estate investment trust, which engages in the ownership, management, and development of income producing properties. It operates through the following segments: Shopping Centers and Mixed-Use Properties. The Shopping Centers segment consists of community and neighbourhood shopping centers which are anchored by supermarkets, discount department stores, and drug stores. The Mixed-Use Properties segment consists of facilities which are located in differing commercial environments with distinctive demographic characteristics and are geographically removed from one another. The company was founded on June 10, 1993 and is headquartered in Bethesda, MD.

Chairman & CEOMr. Bernard Francis Saul II

PresidentMr. David Todd Pearson

Senior VP & CFOMr. Carlos L. Heard

Senior VP and Chief Acquisitions & Development OfficerMr. John F. Collich

Senior VP of Residential Design & Market Research and DirectorMs. Willoughby B. Laycock

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pearson David Todd	President & COO	May 28 '26	Buy	34.74	2,600	90,337	79,321	Jun 01 11:06 AM
Heard Carlos Lawrence	Senior Vice President & CFO	Mar 30 '26	Buy	20.60	500	10,300	4,500	Apr 01 09:05 AM
Guevara Bettina T.	Exec. VP /Chf Legal & Adm Off	Mar 11 '26	Option Exercise	0.00	1,000	0	6,805	Mar 12 05:24 PM
SAUL B FRANCIS II	Chairman & CEO	Mar 11 '26	Option Exercise	0.00	8,000	0	236,154	Mar 12 05:24 PM
Collich John	Sr. VP, Chief Acq. & Dev. Off.	Mar 11 '26	Option Exercise	0.00	600	0	49,860	Mar 12 05:24 PM
Garland Judith K.	SVP, Office and Retail	Mar 11 '26	Option Exercise	0.00	500	0	3,239	Mar 12 05:24 PM
Hachey Donald A	SVP-Chief Construction Officer	Mar 11 '26	Option Exercise	0.00	600	0	3,969	Mar 12 05:24 PM
Lotuff Patricia Saul	Vice Chair	Mar 11 '26	Option Exercise	0.00	800	0	21,434	Mar 12 05:24 PM
Pearson David Todd	President & COO	Mar 11 '26	Option Exercise	0.00	7,000	0	57,619	Mar 12 05:24 PM
Friedman Joel Albert	Exec VP, CAO & Treasurer	Mar 11 '26	Option Exercise	0.00	800	0	5,610	Mar 12 05:24 PM
Godby Lori	Senior Vice Pres.-Residential	Mar 11 '26	Option Exercise	0.00	200	0	1,316	Mar 12 05:23 PM
Laycock Willoughby B.	SVP-Res. Design/Mrkt Research	Mar 11 '26	Option Exercise	0.00	200	0	4,270	Mar 12 05:23 PM
Friedlis Zachary Maxwell	Sr. VP-Director of Leasing	Mar 11 '26	Option Exercise	0.00	600	0	4,906	Mar 12 05:23 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Mar 11 '26	Option Exercise	0.00	800	0	5,531	Mar 12 05:23 PM
CLANCY GEORGE PATRICK JR	Director	Jan 05 '26	Option Exercise	31.50	3,690	116,235	20,605	Jan 06 01:19 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 20 '25	Buy	20.55	300	6,165	4,000	Nov 20 02:13 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 17 '25	Buy	20.54	600	12,324	3,100	Nov 18 03:59 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 18 '25	Buy	20.35	600	12,210	3,700	Nov 18 03:59 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 14 '25	Buy	20.50	450	9,225	2,500	Nov 18 03:59 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 11 '25	Buy	20.85	450	9,382	1,150	Nov 13 04:54 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 12 '25	Buy	20.70	450	9,315	1,600	Nov 13 04:54 PM
Heard Carlos Lawrence	Senior Vice President & CFO	Nov 13 '25	Buy	20.60	450	9,270	2,050	Nov 13 04:54 PM
Collich John	Sr. VP, Chief Acq. & Dev. Off.	Nov 12 '25	Buy	29.99	2,000	59,987	49,260	Nov 13 04:54 PM
Pearson David Todd	President & COO	Nov 12 '25	Buy	29.86	3,348	99,978	50,567	Nov 13 04:53 PM

Open in Screener

BZUN

Baozun Inc ADR

Jun 01 • 02:33PM ET

2.73

+0.14 5.60 %

Consumer Cyclical • Internet Retail • China • Micro • NASD

Peers: DOYU FLX GLBE HUYA ZH DIBS CARG BILI BIDU RUM

| Held by: AVDV DFEM DFAE EWX PGJ APIE DFAX DFEV DFSE AVDS

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	0.17%	Shs Outstand	53.67M	Perf Week	9.40%
Market Cap	146.79M	Forward P/E	4.24	EPS next Y	0.64	Insider Trans	303.15%	Shs Float	53.58M	Perf Month	0.55%
Enterprise Value	320.94M	PEG	-	EPS next Q	-	Inst Own	23.89%	Short Float	1.01%	Perf Quarter	10.73%
Income	-26.09M	P/S	0.10	EPS this Y	122.02%	Inst Trans	1.71%	Short Ratio	1.48	Perf Half Y	-1.26%
Sales	1.45B	P/B	0.30	EPS next Y	57.51%	ROA	-1.89%	Short Interest	0.54M	Perf YTD	2.82%
Book/sh	9.03	P/C	0.34	EPS next 5Y	-	ROE	-4.95%	52W High	4.88 -43.95%	Perf Year	-4.04%
Cash/sh	7.95	P/FCF	-	EPS past 3/5Y	28.42% -	ROIC	-4.42%	52W Low	2.07 32.13%	Perf 3Y	-32.97%
Dividend Est.	-	EV/EBITDA	20.99	Sales past 3/5Y	3.51% 1.53%	Gross Margin	73.15%	Volatility	3.77% 4.13%	Perf 5Y	-92.64%
Dividend TTM	-	EV/Sales	0.22	EPS Y/Y TTM	-5.82%	Oper. Margin	0.76%	ATR (14)	0.13	Perf 10Y	-55.53%
Dividend Ex-Date	-	Quick Ratio	1.49	Sales Y/Y TTM	9.72%	Profit Margin	-1.80%	RSI (14)	56.09	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	1.82	EPS Q/Q	87.67%	SMA20	3.71%	Beta	0.51	Target Price	4.22
Payout	-	Debt/Eq	0.63	Sales Q/Q	21.21%	SMA50	4.71%	Rel Volume	0.75	Prev Close	2.59
Employees	6762	LT Debt/Eq	0.13	Earnings	May 20 BMO	SMA200	-8.06%	Avg Volume	366.47K	Price	2.73
IPO	May 21, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	- 4.25%	Trades		Volume	218,928	Change	5.60%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-30-24	Downgrade	CLSA	Outperform → Hold
Mar-26-24	Downgrade	China Renaissance	Buy → Hold
Feb-08-24	Upgrade	Daiwa Securities	Outperform → Buy
Feb-27-23	Upgrade	CLSA	Underperform → Outperform	$4.40 → $7
Jan-30-23	Initiated	JP Morgan	Overweight
Jan-11-23	Upgrade	JP Morgan	Neutral → Overweight	$9 → $10
May-16-22	Upgrade	JP Morgan	Underweight → Neutral	$5 → $8
Mar-14-22	Downgrade	JP Morgan	Overweight → Underweight	$5
Mar-11-22	Upgrade	Credit Suisse	Underperform → Neutral	$8.30
Dec-02-21	Downgrade	CLSA	Buy → Outperform
Aug-20-21	Downgrade	Daiwa Securities	Buy → Neutral	$42 → $20
Jul-23-21	Downgrade	Credit Suisse	Outperform → Underperform
Jun-08-21	Resumed	JP Morgan	Overweight	$45
May-19-21	Upgrade	Credit Suisse	Neutral → Outperform	$41
Jan-25-21	Upgrade	CLSA	Outperform → Buy	$42
Nov-24-20	Downgrade	Credit Suisse	Outperform → Neutral
Jun-03-20	Upgrade	Credit Suisse	Neutral → Outperform	$36
Mar-31-20	Downgrade	BofA/Merrill	Buy → Neutral
Nov-22-19	Downgrade	Credit Suisse	Outperform → Neutral
Aug-22-19	Downgrade	CLSA	Buy → Outperform

Show Previous Ratings

May-20-26 03:01PM	Baozun Inc (BZUN) Q1 2026 Earnings Call Highlights: Revenue Surge and Profit Turnaround (GuruFocus.com)
06:00AM	Baozun Announces First Quarter 2026 Unaudited Financial Results (PR Newswire)
May-15-26 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire) -8.89%
May-08-26 06:00AM	Baozun to Announce First Quarter 2026 Unaudited Financial Results on May 20, 2026 (PR Newswire)
Apr-23-26 07:42AM	Baozun Releases 2025 Annual Sustainability Report (PR Newswire)
06:50AM	Loading…
06:50AM	Baozun Files Annual Reports for Fiscal Year 2025 (PR Newswire)
06:00AM	Baozun Releases 2025 Chairman Letter (PR Newswire)
Mar-26-26 02:39PM	Gap Plans 50 China Stores After First Quarterly Breakeven (GuruFocus.com) -12.10%
Mar-25-26 03:01PM	Baozun Inc (BZUN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Profitability ... (GuruFocus.com) +16.43%
06:15AM	Baozun Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results (PR Newswire)
Mar-11-26 06:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 25, 2026 (PR Newswire)
Nov-25-25 02:00PM	Baozun Inc (BZUN) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Focus on ... (GuruFocus.com) -5.82%
05:00AM	Baozun Announces Third Quarter 2025 Unaudited Financial Results (PR Newswire)
Nov-11-25 05:00AM	Baozun to Announce Third Quarter 2025 Unaudited Financial Results on November 25, 2025 (PR Newswire)
Sep-22-25 01:32PM	Accenture Pre-Q4 Earnings: Is the Stock a Portfolio Must-Have? (Zacks)
03:04AM	Loading…
Aug-29-25 03:04AM	Baozun Inc (BZUN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion (GuruFocus.com) +6.27%
Aug-28-25 06:00AM	Baozun Announces Second Quarter 2025 Unaudited Financial Results (PR Newswire) +12.72%
Aug-14-25 06:00AM	Baozun to Announce Second Quarter 2025 Unaudited Financial Results on August 28, 2025 (PR Newswire)
Jul-21-25 09:40AM	Is Baozun (BZUN) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
Jun-18-25 06:00AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-22-25 03:03AM	Baozun Inc (BZUN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com)
May-21-25 06:00AM	Baozun Announces First Quarter 2025 Unaudited Financial Results (PR Newswire)
May-16-25 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
May-07-25 06:00AM	Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025 (PR Newswire) +6.84%
Apr-23-25 07:17AM	Baozun Releases 2024 Sustainability Report (PR Newswire)
06:38AM	Baozun Files Annual Reports for Fiscal Year 2024 (PR Newswire)
06:00AM	Baozun Releases 2024 Chairman Letter (PR Newswire)
Apr-18-25 11:35AM	Is Baozun Inc. (BZUN) the Best Internet Retail Stock to Buy According to Analysts? (Insider Monkey)
Mar-30-25 08:00AM	Baozun: Decent Buy Opportunity After The Correction (Seeking Alpha)
Mar-21-25 03:01AM	Baozun Inc (BZUN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
12:30PM	Loading…
Mar-20-25 12:30PM	Baozun (BZUN) Q4 2024 Earnings Call Transcript (Motley Fool) -12.71%
09:01AM	Baozun Inc. (BZUN) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results (PR Newswire)
Mar-19-25 06:00PM	Here's the major earnings before the open tomorrow (SeekingAlpha)
Mar-06-25 05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 (PR Newswire)
Feb-27-25 10:32AM	Why Baozun Inc. (BZUN) Is Skyrocketing So Far In 2025 (Insider Monkey) -5.52%
Feb-10-25 07:56PM	Why Baozun Inc. (BZUN) Is Skyrocketing (Insider Monkey)
Nov-22-24 02:02AM	Baozun Inc (BZUN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Profitability ... (GuruFocus.com)
Nov-21-24 11:00AM	Baozun (BZUN) Q3 2024 Earnings Call Transcript (Motley Fool) -8.11%
05:00AM	Baozun Announces Third Quarter 2024 Unaudited Financial Results (PR Newswire)
Nov-07-24 05:00AM	Baozun to Announce Third Quarter Financial Results of 2024 Unaudited Financial Results on November 21, 2024 (PR Newswire)
Oct-17-24 06:28AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-16-24 06:50AM	Baozun Inc. Announces Strategic Share Repurchase (TipRanks)
Oct-10-24 06:29AM	Baozun Announces Share Repurchase Update (TipRanks)
Oct-09-24 07:27AM	Baozun Announces Recent Share Repurchase (TipRanks)
Oct-08-24 07:17AM	Baozun Announces Recent Share Repurchase (TipRanks) -10.22%
Oct-05-24 06:31AM	Baozun Announces Share Repurchase Update (TipRanks)
Aug-28-24 02:30PM	Baozun (BZUN) Q2 2024 Earnings Call Transcript (Motley Fool)
06:28AM	Baozun Announces Second Quarter 2024 Unaudited Financial Results (PR Newswire)
Aug-14-24 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2024 Unaudited Financial Results on August 28, 2024 (PR Newswire)
Jun-12-24 07:26AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
May-31-24 05:30AM	Alibaba sells stake in e-commerce branding services firm Baozun for US$21.8 million as part of corporate restructuring (South China Morning Post)
May-29-24 08:03AM	Baozun Inc. (NASDAQ:BZUN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-28-24 01:00PM	Baozun (BZUN) Q1 2024 Earnings Call Transcript (Motley Fool)
10:52AM	BZUN Stock Earnings: Baozun Beats Revenue for Q1 2024 (InvestorPlace)
06:00AM	Baozun Announces First Quarter 2024 Unaudited Financial Results (PR Newswire)
May-14-24 06:00AM	Baozun to Announce First Quarter 2024 Unaudited Financial Results on May 28, 2024 (PR Newswire)
May-10-24 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (PR Newswire)
Apr-19-24 07:13AM	Baozun Releases 2023 Sustainability Report (PR Newswire)
06:34AM	Baozun Strengthens Leadership Team (PR Newswire)
06:26AM	Baozun Files Annual Reports for Fiscal Year 2023 (PR Newswire)
06:00AM	Baozun Releases 2023 Chairman Letter (PR Newswire)
Mar-26-24 08:51AM	Baozun Inc. (NASDAQ:BZUN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-21-24 12:45PM	Baozun (BZUN) Q4 2023 Earnings Call Transcript (Motley Fool) -16.67%
10:53AM	BZUN Stock Earnings: Baozun Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Baozun Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results (PR Newswire)
Mar-07-24 04:32PM	7 Under-$10 Stocks That Will Be Worth $100 (or More!) by 2026 (InvestorPlace)
05:00AM	Baozun to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results on March 21, 2024 (PR Newswire)
Feb-16-24 03:15AM	20 Fastest Growing E-Commerce Companies in 2024 (Insider Monkey)
Jan-24-24 06:00AM	Baozun Announces US$20 million Share Repurchase Program (PR Newswire) +17.33%
Nov-24-23 08:44AM	Baozun Inc. (NASDAQ:BZUN) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.46%
Nov-22-23 10:45AM	Baozun (BZUN) Q3 2023 Earnings Call Transcript (Motley Fool) -10.12%
05:00AM	Baozun Announces Third Quarter 2023 Unaudited Financial Results (PR Newswire)
Nov-08-23 05:00AM	Baozun to Announce Third Quarter Financial Results of 2023 Unaudited Financial Results on November 22, 2023 (PR Newswire)
Oct-05-23 05:17PM	Ray Dalio on Potential US-China War and Rise of China (Insider Monkey) +5.72%
Aug-29-23 08:12AM	Baozun Inc. (NASDAQ:BZUN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-28-23 03:39PM	Why Baozun Stock Popped Today (Motley Fool) +12.47%
01:00PM	Baozun (BZUN) Q2 2023 Earnings Call Transcript (Motley Fool)
12:37PM	Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories (Benzinga)
06:00AM	Baozun Announces Second Quarter 2023 Unaudited Financial Results (PR Newswire)
Aug-14-23 06:00AM	Baozun to Announce Second Quarter and Half-Year Interim Financial Results of 2023 Unaudited Financial Results on August 28, 2023 (PR Newswire)
Jul-14-23 10:22AM	Positive week for Baozun Inc. (NASDAQ:BZUN) institutional investors who lost 52% over the past year (Simply Wall St.)
Jun-27-23 04:18PM	Why Alibaba, Bilibili, and Baozun Rose Today (Motley Fool)
Jun-15-23 08:20AM	Baozun Announces Results of Annual General Meeting of Shareholders (PR Newswire)
Jun-02-23 11:54AM	Why Shares of Alibaba, Dingdong, and Baozun Are Rising Today (Motley Fool)
May-25-23 02:47PM	Why Baozun Stock Was Falling Today (Motley Fool) -9.65%
01:30PM	Baozun (BZUN) Q1 2023 Earnings Call Transcript (Motley Fool)
06:00AM	Baozun Announces First Quarter 2023 Unaudited Financial Results (PR Newswire)
May-15-23 06:00AM	Baozun Schedules Annual General Meeting of Shareholders (GlobeNewswire) +7.57%
May-12-23 06:00AM	Baozun to Announce First Quarter 2023 Unaudited Financial Results on May 25, 2023 (GlobeNewswire) -5.42%
Apr-29-23 08:34AM	Baozun (NASDAQ:BZUN) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Apr-25-23 06:34AM	Baozun Releases 2022 Sustainability Report (GlobeNewswire)
06:27AM	Baozun Files Annual Report on Form 20-F for Fiscal Year 2022 (GlobeNewswire)
06:19AM	Baozun Releases 2022 Chairman Letter (GlobeNewswire)
Mar-25-23 08:41AM	Baozun Full Year 2022 Earnings: Misses Expectations (Simply Wall St.)
Mar-24-23 07:15AM	Baozun Inc. (NASDAQ:BZUN) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.26%
06:42AM	Baozun (NASDAQ:BZUN) Might Be Having Difficulty Using Its Capital Effectively (Simply Wall St.)
Mar-22-23 12:18PM	Why Baozun Stock Was Sinking Today (Motley Fool) -9.41%
10:08AM	Baozun Registers 20% Topline Decline In Q4 Weighed Down By GMV Weakness; Updates On Newer Business Lines (Benzinga)
06:30AM	Baozun Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results (GlobeNewswire)

Baozun, Inc. is a holding company, which engages in the provision of brand electronic commerce (e-commerce) services and solutions. Its services include apparel and accessories, appliances, electronics, home and furnishings, food and health products, beauty and cosmetics, fast moving consumer goods, and mother and baby products, and insurance and automobiles. The firm operates through the E-Commerce and Brand Management segments. The company was founded by Wen Bin Qiu, Jun Hua Wu, and Qing Yu Zhang in August 2007 and is headquartered in Shanghai, China.

Co-FounderMr. Wenbin Qiu

Co-FounderMr. Junhua Wu

Chief Financial OfficerMs. Yanjie Zhu

Joint Company Secretary and Senior Director of Corporate Development & Investor RelationsMs. Wendy Shu Sun

Senior Vice PresidentMr. Yuen Lung Kwok

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wu Junhua	Chief Strategy Officer	May 28 '26	Buy	2.56	19,500	49,920	168,270	Jun 01 07:53 AM
Qiu Wenbin	Chief Executive Officer	May 29 '26	Buy	2.57	10,000	25,700	1,473,872	Jun 01 07:46 AM
Qiu Wenbin	Chief Executive Officer	May 28 '26	Buy	2.56	10,000	25,600	1,463,872	Jun 01 07:46 AM
Qiu Wenbin	Chief Executive Officer	May 27 '26	Buy	2.58	10,000	25,800	1,453,872	May 28 06:48 AM
Qiu Wenbin	Chief Executive Officer	May 26 '26	Buy	2.55	10,000	25,500	1,443,872	May 28 06:48 AM
Wu Junhua	Chief Strategy Officer	May 26 '26	Buy	2.55	10,000	25,500	148,770	May 28 06:45 AM
Qiu Wenbin	Chief Executive Officer	Apr 17 '26	Buy	3.14	16,000	50,240	1,433,872	Apr 21 06:15 AM
Qiu Wenbin	Chief Executive Officer	Apr 16 '26	Buy	2.84	17,500	49,700	1,417,872	Apr 17 07:33 AM
Qiu Wenbin	Chief Executive Officer	Apr 15 '26	Buy	2.71	11,000	29,810	1,400,372	Apr 17 07:33 AM
Qiu Wenbin	Chief Executive Officer	Apr 14 '26	Buy	2.63	11,500	30,245	1,389,372	Apr 15 06:30 AM
Qiu Wenbin	Chief Executive Officer	Apr 13 '26	Buy	2.48	12,100	30,008	1,377,872	Apr 15 06:30 AM
Wu Junhua	Chief Strategy Officer	Apr 13 '26	Buy	2.49	11,084	27,599	138,770	Apr 14 07:47 AM
Wu Junhua	Chief Strategy Officer	Apr 10 '26	Buy	2.40	5,372	12,893	127,686	Apr 14 07:47 AM
Qiu Wenbin	Chief Executive Officer	Apr 10 '26	Buy	2.43	12,400	30,132	1,365,772	Apr 13 06:19 AM
Qiu Wenbin	Chief Executive Officer	Apr 09 '26	Buy	2.58	11,650	30,057	1,353,372	Apr 13 06:19 AM
Wu Junhua	Chief Strategy Officer	Apr 08 '26	Buy	2.54	30,886	78,450	122,314	Apr 10 06:18 AM
Qiu Wenbin	Chief Executive Officer	Apr 07 '26	Buy	2.51	12,000	30,120	1,330,122	Apr 09 06:31 AM
Qiu Wenbin	Chief Executive Officer	Apr 08 '26	Buy	2.58	11,600	29,928	1,341,722	Apr 09 06:31 AM
Wu Junhua	Chief Strategy Officer	Apr 02 '26	Buy	2.47	30,000	74,019	91,428	Apr 06 08:47 AM
Wu Junhua	Chief Strategy Officer	Mar 31 '26	Buy	2.40	14,000	33,597	61,428	Apr 01 09:52 PM

Open in Screener

MTDR

Matador Resources Co

Jun 01 • 02:36PM ET

56.01

+2.41 4.49 %

Energy • Oil & Gas E&P • USA • Mid • NYSE

MTDR Matador Resources Co daily Stock Chart

Peers: MGY SM CHRD PR APA MUR OVV RRC CRK EQT

| Held by: VTI IJH VB VBR XOP VXF AVUV FXN DFAT MDY

Index	-	P/E	14.42	EPS (ttm)	3.88	Insider Own	7.35%	Shs Outstand	124.21M	Perf Week	-1.12%
Market Cap	6.95B	Forward P/E	6.36	EPS next Y	8.80	Insider Trans	0.06%	Shs Float	115.06M	Perf Month	-11.72%
Enterprise Value	10.66B	PEG	0.43	EPS next Q	2.25	Inst Own	95.10%	Short Float	9.17%	Perf Quarter	3.48%
Income	483.26M	P/S	1.94	EPS this Y	34.96%	Inst Trans	2.09%	Short Ratio	5.68	Perf Half Y	34.40%
Sales	3.59B	P/B	1.25	EPS next Y	13.25%	ROA	4.16%	Short Interest	10.55M	Perf YTD	31.96%
Book/sh	44.96	P/C	75.21	EPS next 5Y	14.72%	ROE	8.89%	52W High	66.84 -16.21%	Perf Year	30.21%
Cash/sh	0.74	P/FCF	117.06	EPS past 3/5Y	-15.52% -	ROIC	5.34%	52W Low	37.14 50.80%	Perf 3Y	24.40%
Dividend Est.	1.52 (2.72%)	EV/EBITDA	4.56	Sales past 3/5Y	4.58% 33.72%	Gross Margin	38.90%	Volatility	3.20% 3.56%	Perf 5Y	73.07%
Dividend TTM	1.44 (2.57%)	EV/Sales	2.97	EPS Y/Y TTM	-47.92%	Oper. Margin	31.24%	ATR (14)	2.33	Perf 10Y	144.99%
Dividend Ex-Date	May 08, 2026	Quick Ratio	0.70	Sales Y/Y TTM	-2.91%	Profit Margin	13.45%	RSI (14)	46.26	Recom	1.52
Dividend Gr. 3/5Y	63.45% -	Current Ratio	0.73	EPS Q/Q	-115.17%	SMA20	-2.46%	Beta	0.74	Target Price	73.75
Payout	21.54%	Debt/Eq	0.62	Sales Q/Q	-6.42%	SMA50	-5.86%	Rel Volume	0.50	Prev Close	53.60
Employees	483	LT Debt/Eq	0.62	Earnings	May 06 AMC	SMA200	14.31%	Avg Volume	1.86M	Price	56.01
IPO	Feb 02, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.45% -22.94%	Trades		Volume	745,810	Change	4.49%

Date	Action	Analyst	Rating Change	Price Target Change
May-12-26	Upgrade	Truist	Hold → Buy	$67
Apr-08-26	Downgrade	Roth Capital	Buy → Neutral	$65
Mar-24-26	Initiated	Truist	Hold	$60
Jan-27-26	Downgrade	Wells Fargo	Overweight → Equal Weight	$47
Dec-08-25	Initiated	Citigroup	Buy	$53
Aug-25-25	Initiated	William Blair	Outperform
May-19-25	Initiated	BofA Securities	Buy	$56
Apr-22-25	Initiated	UBS	Neutral	$47
Jan-10-25	Initiated	Morgan Stanley	Equal-Weight	$78
Jan-03-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$72
Jul-25-24	Upgrade	CapitalOne	Equal Weight → Overweight	$80 → $84
Jul-18-24	Initiated	Wolfe Research	Peer Perform
Jun-21-24	Initiated	Stephens	Overweight	$83
Nov-15-23	Initiated	Wells Fargo	Overweight	$73
Aug-16-23	Upgrade	Mizuho	Neutral → Buy	$66 → $78
Jan-10-23	Initiated	Mizuho	Neutral	$70
Sep-21-22	Resumed	MKM Partners	Buy	$68
Sep-20-22	Initiated	KeyBanc Capital Markets	Overweight	$72
Nov-19-21	Upgrade	Wells Fargo	Equal Weight → Overweight	$46 → $53
Oct-28-21	Downgrade	CapitalOne	Overweight → Equal Weight	$46 → $44

Show Previous Ratings

May-28-26 04:15PM	Matador Resources Company Announces 2026 Annual Meeting and Webcast Details (Business Wire)
May-22-26 06:48AM	Matador acquires 5,154 net acres in Delaware Basin for $1.14bn (Offshore Technology)
May-21-26 08:04PM	Matador Expands Delaware Basin Footprint in $1.1 Billion Lease Deal (Oilprice.com) -5.76%
04:40PM	Matador Resources Company Announces Successful Acquisitions in Federal Lease Sale (Business Wire)
May-12-26 09:56AM	Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls (The Fly)
08:30AM	Loading…
May-07-26 08:30AM	Matador Resources Company Q1 2026 Earnings Call Summary (Moby)
May-06-26 04:33PM	Matador: Q1 Earnings Snapshot (Associated Press) -8.22%
04:15PM	Matador Resources Company Reports First Quarter 2026 Results, Increases Production Guidance and Reaffirms Existing Capital Spending (Business Wire)
Apr-27-26 04:30PM	Matador Resources Company Announces Leadership Promotions (Business Wire)
Apr-22-26 04:15PM	Matador Resources Company Declares Quarterly Cash Dividend (Business Wire)
Apr-14-26 06:30AM	Matador Resources Company Announces Date of First Quarter 2026 Earnings Release (Business Wire)
Mar-09-26 12:00PM	5 Big Takeaways From the Middle East Energy Shock (Barrons.com)
Mar-05-26 06:30AM	Matador Resources Company Announces Expiration and Results of Cash Tender Offer for Any and All of Its Outstanding 6.875% Senior Notes Due 2028 (Business Wire)
Mar-02-26 08:18AM	MTDR Q4 Earnings & Revenues Beat on Higher Production Volumes (Zacks) +5.29%
Feb-28-26 12:35PM	Matador Resources Q4 Earnings Call Highlights (MarketBeat)
04:49PM	Loading…
Feb-27-26 04:49PM	Matador Resources (MTDR) Reports Record Production and 9% Proved Reserve Growth for 2025 (Insider Monkey) +5.29%
Feb-26-26 04:22PM	Matador Resources Company Prices Offering of $750 Million of Senior Notes Due 2034 (Business Wire)
07:43AM	Matador Resources Company Announces Cash Tender Offer for Any and All of Its Outstanding 6.875% Senior Notes Due 2028 (Business Wire)
07:41AM	Matador Resources Company Announces Offering of $750 Million of Senior Notes Due 2034 (Business Wire)
Feb-25-26 06:00PM	Matador Resources Co (MTDR) Q4 2025 Earnings Call Highlights: Strong Reserves Growth and Debt ... (GuruFocus.com)
Feb-24-26 07:30PM	Matador Resources (MTDR) Q4 Earnings and Revenues Top Estimates (Zacks)
04:47PM	Matador: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Matador Resources Company Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Operating Plan and Market Guidance (Business Wire)
Feb-23-26 10:23AM	Do Options Traders Know Something About Matador Resources Stock We Don't? (Zacks)
Feb-19-26 11:03AM	Matador Resources (MTDR) Downgraded to 'Equal Weight' (Insider Monkey)
Feb-18-26 10:00AM	Earnings Preview: APA (APA) Q4 Earnings Expected to Decline (Zacks)
Feb-17-26 04:15PM	Matador Resources Company Declares Quarterly Cash Dividend (Business Wire)
10:00AM	Analysts Estimate Matador Resources (MTDR) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-11-26 08:19AM	Top 3 Energy Stocks with Massive Upside Potential According to WarrenAI (Investing.com)
Feb-03-26 04:34AM	Benchmark Sees Midstream Monetization Unlocking Value for Matador Resources (MTDR) (Insider Monkey)
09:37AM	Loading…
Jan-27-26 09:37AM	Target upgraded, Stryker downgraded: Wall Street's top analyst calls (The Fly)
06:30AM	Matador Resources Increases Hedge Position and Provides Updates on 2025 A&D Activity and Improved Well Performance (Business Wire)
Jan-22-26 03:22AM	Analysts Expect Matador Resources Company (MTDR) to Navigate Lower Oil Prices Effectively (Insider Monkey)
Jan-19-26 06:30AM	Matador Resources Company Announces Date of Fourth Quarter and Full Year 2025 Earnings Release (Business Wire)
Jan-14-26 07:00AM	Top Energy Stocks Poised for Gains: WarrenAI Highlights Value Opportunities (Investing.com)
Jan-12-26 12:48PM	Upstream Operators Adjust Strategies as Oil Moderates, Gas Supports (Zacks)
Dec-30-25 04:39PM	Insiders Made Their Bets in 2025-These Were the Top 5 Stocks They Bought (MarketBeat)
Dec-28-25 10:59AM	Here's What You Need to Know About Matador Resources Company (MTDR) (Insider Monkey)
Dec-18-25 09:41AM	Carbon TerraVault and Power Deals Reshape CRC Optionality (Zacks)
07:00AM	UBS Reiterates a Hold Rating on Matador Resources Company (MTDR) (Insider Monkey)
Dec-17-25 10:14AM	CRC Valuation Check and Entry Setup for Pragmatic Buyers (Zacks)
Dec-11-25 06:30AM	Matador Resources Announces Successful RBL Redetermination and Increase in San Mateo Bank Commitments (Business Wire)
Dec-08-25 10:28AM	CRC Builds a Steadier Cash Flow Base as Policy Tailwinds Grow (Zacks)
10:13AM	CRC Advances CCS and Methane Strategy as 2026 Milestones Near (Zacks)
Dec-05-25 11:59AM	Are Options Traders Betting on a Big Move in Matador Resources Stock? (Zacks)
11:50AM	California Resources 2026 Outlook: Policy Shifts and Berry Merger (Zacks)
Dec-03-25 11:30AM	Why Is Diamondback (FANG) Up 11.9% Since Last Earnings Report? (Zacks)
Nov-28-25 11:30AM	Magnolia Oil & Gas Corp (MGY) Up 2.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-20-25 11:30AM	Why Is Matador (MTDR) Up 3.4% Since Last Earnings Report? (Zacks)
Oct-30-25 09:39PM	Matador Resources (MTDR) Reports Financial and Operating Results for Q3 2025 (Insider Monkey)
06:30AM	Matador Resources Company Provides Strategic Natural Gas Marketing Update (Business Wire)
Oct-27-25 09:30AM	Matador (MTDR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
Oct-24-25 06:30PM	Matador (MTDR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Oct-22-25 05:02PM	Matador Resources Co (MTDR) Q3 2025 Earnings Call Highlights: Record Retained Earnings and ... (GuruFocus.com) -9.63%
09:29AM	Matador Q3 Earnings & Revenues Beat on Higher Production Volumes (Zacks)
Oct-21-25 06:20PM	Matador Resources (MTDR) Tops Q3 Earnings and Revenue Estimates (Zacks)
05:19PM	Matador: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Matador Resources Company Reports Third Quarter 2025 Results, Increases Full-year 2025 Guidance and Provides 2026 Outlook (Business Wire)
Oct-16-25 01:04PM	Matador Resources Gears Up to Report Q3 Earnings: What's in Store? (Zacks)
Oct-15-25 04:15PM	Matador Resources Company Increases Quarterly Cash Dividend (Business Wire)
Oct-14-25 10:00AM	Earnings Preview: Matador Resources (MTDR) Q3 Earnings Expected to Decline (Zacks)
Oct-05-25 09:27PM	Matador Resources (MTDR) Falls Amid Declining Oil Prices (Insider Monkey)
Oct-03-25 12:10PM	Will Matador (MTDR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
06:30AM	Matador Resources Company Announces Date of Third Quarter 2025 Earnings Release (Business Wire)
Sep-30-25 06:30AM	Matador Resources Company Announces Promotion of Robert T. Macalik to Chief Financial Officer (Business Wire)
Sep-29-25 08:50AM	Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now (Zacks) -6.90%
Sep-12-25 09:10AM	3 Mid-Cap Energy Firms Analysts See Moving Up to the Big Leagues (MarketBeat)
Sep-04-25 12:55PM	KeyBanc Reduces PT on Matador Resources (MTDR) Stock (Insider Monkey)
Sep-03-25 11:37AM	Is PrimeEnergy Stock a Smart Bet Amid Oil Slump & Gas Growth? (Zacks)
11:30AM	Diamondback (FANG) Up 2.9% Since Last Earnings Report: Can It Continue? (Zacks)
Sep-02-25 12:46AM	William Blair Initiates Coverage of Matador Resources Company (MTDR) With an Outperform Rating (Insider Monkey)
Aug-29-25 11:30AM	Antero Resources (AR) Down 8% Since Last Earnings Report: Can It Rebound? (Zacks)
12:26AM	Roth MKM Maintains a Buy on Matador Resources Company (MTDR) (Insider Monkey)
Aug-25-25 11:29AM	UBS Lowers PT on Matador Resources (MTDR) to $48 From $49, Keeps a Neutral Rating (Insider Monkey)
Aug-21-25 11:30AM	Matador (MTDR) Down 8.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-17-25 11:56PM	KeyBanc Hikes Matador Resources (MTDR) Price Target amid Mixed Q2 Results (Insider Monkey)
Jul-28-25 09:30AM	Matador (MTDR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Jul-23-25 10:39AM	Matador Resources Q2 Earnings Beat on Higher Production Volumes (Zacks)
09:15AM	Back-to-Back Catalysts Line Up for U.S. Oil and Gas Producers as Domestic Output Tightens (PR Newswire)
Jul-22-25 05:30PM	Matador Resources (MTDR) Tops Q2 Earnings Estimates (Zacks)
04:27PM	Matador: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Matador Resources Company Reports Second Quarter 2025 Results and Updates Full Year 2025 Guidance (Business Wire)
07:31AM	Phillips 66 to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-21-25 08:27AM	Valero Energy to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-18-25 01:21PM	Dividends Declared Week of July 14 (Hart Energy)
Jul-17-25 10:00AM	CNX Resources Corporation. (CNX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:50AM	How to Find Strong Oils and Energy Stocks Slated for Positive Earnings Surprises (Zacks)
Jul-15-25 04:19PM	Matador Resources Company Declares Quarterly Cash Dividend (Business Wire)
10:24AM	AI's Power Hunger Collides with America's Oil Patch in a High-Stakes Energy Rush (PR Newswire)
10:00AM	Matador Resources (MTDR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:50AM	How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings (Zacks)
Jul-09-25 06:20AM	Should You Invest in the First Trust Energy AlphaDEX ETF (FXN)? (Zacks)
Jul-08-25 12:10PM	Will Matador (MTDR) Beat Estimates Again in Its Next Earnings Report? (Zacks) +6.73%
10:57AM	Sizzling Insider Buys for Your High-Yield Watchlist (MarketBeat)
Jun-28-25 04:16AM	Matador Resources Expands Gas Processing Capacity to 720 MMcf/d with Marlan Plant Startup (Insider Monkey)
Jun-18-25 06:30AM	Matador Resources Company Announces Date of Second Quarter 2025 Earnings Release (Business Wire)
Jun-12-25 06:30AM	Matador Resources Company and San Mateo Midstream Announce Leadership Promotions (Business Wire)
Jun-06-25 10:51AM	Here's Why You Should Hold On to Range Resources Stock Right Now (Zacks)
May-29-25 06:30AM	Matador Resources Company Announces Start up of Marlan Plant Expansion, Credit Rating Upgrade and Borrowing Base Reaffirmation (Business Wire)
May-23-25 11:30AM	Matador (MTDR) Up 7% Since Last Earnings Report: Can It Continue? (Zacks)

Matador Resources Co. is a holding company, which engages in the exploration, development, production, and acquisition of oil and natural gas resources. It operates through the following segments: Exploration and Production, Midstream, and Corporate. The Exploration and Production segment focuses on the exploration, development, production, and acquisition of oil and liquids-rich portion of the Wolfcamp and Bone Spring. The Midstream segment conducts natural gas processing, oil transportation services, oil, natural gas and produced water gathering services, and produced water disposal services to third parties. The company was founded by Joseph William Foran and Scott E. King in July 2003 and is headquartered in Dallas, TX.

FounderMr. Joseph Wm. Foran

Co-President LandMr. Van H. Singleton II

Co-PresidentMr. Bryan A. Erman

Executive Vice President of MidstreamMr. Brian J. Willey

Executive VP & CFOMr. Christopher P. Calvert

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stetson Glenn W	EVP and COO	May 28 '26	Buy	53.94	500	26,970	94,970	Jun 01 07:27 AM
Foran Joseph Wm	Chairman and CEO	May 27 '26	Buy	52.36	4,675	244,783	6,997	May 28 07:24 AM
Macalik Robert T	Officer	May 11 '26	Proposed Sale	55.26	103,927	5,743,006		May 11 10:02 AM
Ehrman Monika U	Director	Mar 06 '26	Buy	56.29	267	15,029	41,463	Mar 10 07:26 AM
Foran Joseph Wm	Chairman and CEO	Feb 27 '26	Buy	49.78	468	23,297	2,322	Mar 03 07:21 AM
Macalik Robert T	EVP, Chief Financial Officer	Nov 06 '25	Buy	38.25	1,500	57,375	35,039	Nov 10 07:34 AM
Singleton Van H II	CoPresident-Land, A&D,Planning	Nov 06 '25	Buy	38.28	500	19,140	292,918	Nov 10 07:33 AM
Foran Joseph Wm	Chairman and CEO	Nov 06 '25	Buy	38.14	1,000	38,140	23,867	Nov 10 07:31 AM
Appel Shelley F	Director	Nov 06 '25	Buy	38.01	1,389	52,801	5,084	Nov 06 05:13 PM
Appel Shelley F	Director	Nov 05 '25	Buy	37.52	1,338	50,202	66,859	Nov 06 05:13 PM
Appel Shelley F	Director	Nov 05 '25	Buy	37.55	153	5,745	4,895	Nov 06 05:13 PM
Baribault Reynald	Director	Nov 04 '25	Buy	38.49	400	15,396	6,915	Nov 06 04:22 PM
Foran Joseph Wm	Chairman and CEO	Nov 04 '25	Buy	38.44	4,000	153,760	22,867	Nov 06 07:36 AM
Ward Susan M	Director	Nov 03 '25	Buy	39.04	5,000	195,200	14,923	Nov 05 04:18 PM
Calvert Christopher P	EVP and COO	Nov 03 '25	Buy	39.44	2,500	98,600	40,000	Nov 05 07:37 AM
Singleton Van H II	CoPresident-Land, A&D,Planning	Nov 03 '25	Buy	39.46	1,000	39,460	292,418	Nov 05 07:36 AM
Baty Robert Gaines	Director	Oct 31 '25	Buy	39.51	500	19,755	73,396	Nov 04 04:53 PM
Elsener William Thomas	EVP, Reservoir Engineering	Oct 31 '25	Buy	39.51	600	23,706	112,669	Nov 04 04:52 PM
Macalik Robert T	EVP, Chief Financial Officer	Oct 31 '25	Buy	39.40	1,039	40,937	33,539	Nov 04 07:32 AM
Erman Bryan A	Co-President,CLO & Head of M&A	Oct 31 '25	Buy	39.60	1,000	39,600	77,518	Nov 04 07:31 AM
Colodney Benjamin T	VP & Chief Accounting Officer	Oct 30 '25	Buy	39.35	100	3,935	9,840	Nov 03 04:33 PM
Harvey Paul W	Director	Oct 30 '25	Buy	40.30	800	32,240	15,767	Nov 03 04:32 PM
Stetson Glenn W	EVP-Production	Oct 30 '25	Buy	39.95	700	27,965	94,652	Nov 03 04:31 PM
Appel Shelley F	Director	Oct 30 '25	Buy	39.85	1,784	71,092	1,784	Nov 03 04:30 PM
Appel Shelley F	Director	Oct 30 '25	Buy	39.90	1,555	62,044	64,375	Nov 03 04:30 PM
Appel Shelley F	Director	Oct 31 '25	Buy	39.30	636	24,995	65,011	Nov 03 04:30 PM
Appel Shelley F	Director	Nov 03 '25	Buy	39.25	510	20,018	65,521	Nov 03 04:30 PM
Foran Joseph Wm	Chairman and CEO	Oct 30 '25	Buy	39.78	9,500	377,910	17,525	Nov 03 07:00 AM
Foran Joseph Wm	Chairman and CEO	Oct 31 '25	Buy	39.30	1,342	52,741	18,867	Nov 03 07:00 AM
Stetson Glenn W	EVP-Production	Sep 12 '25	Buy	48.52	500	24,260	93,952	Sep 16 07:30 AM
Erman Bryan A	Co-President,CLO & Head of M&A	Sep 12 '25	Buy	47.99	500	23,995	4,250	Sep 16 07:29 AM
Colodney Benjamin T	VP & Chief Accounting Officer	Sep 12 '25	Buy	47.89	130	6,226	2,400	Sep 15 04:18 PM
Lambert William D	EVP and CFO	Sep 12 '25	Buy	48.04	150	7,206	650	Sep 15 04:18 PM
Calvert Christopher P	EVP and COO	Sep 12 '25	Buy	47.77	1,000	47,770	37,500	Sep 15 04:17 PM
Elsener William Thomas	EVP, Reservoir Engineering	Sep 11 '25	Buy	48.46	600	29,076	112,069	Sep 15 07:30 AM
Foran Joseph Wm	Chairman and CEO	Sep 12 '25	Buy	48.15	2,000	96,300	8,025	Sep 15 07:30 AM
Ehrman Monika U	Director	Sep 08 '25	Buy	47.04	250	11,760	41,196	Sep 09 07:15 AM
Foran Joseph Wm	Chairman and CEO	Aug 19 '25	Buy	46.25	2,000	92,500	8,606	Aug 21 07:30 AM
Foran Joseph Wm	Chairman and CEO	Aug 01 '25	Buy	49.17	5,000	245,850	6,606	Aug 05 07:33 AM

Open in Screener

SBMT

Silver Bow Mining Corp

Jun 01 • 02:36PM ET

9.21

-0.79 -7.90 %

Basic Materials • Other Industrial Metals & Mining • USA • Micro • AMEX

SBMT Silver Bow Mining Corp daily Stock Chart

Peers: GMTL MTA VOXR ELE ASM MUX VMET AYA LODE ITRG

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	15.91%	Shs Outstand	29.53M	Perf Week	7.72%
Market Cap	271.97M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	0.38%	Shs Float	24.82M	Perf Month	-14.33%
Enterprise Value	268.45M	PEG	-	EPS next Q	-	Inst Own	8.73%	Short Float	0.12%	Perf Quarter	-
Income	-7.00M	P/S	-	EPS this Y	14.75%	Inst Trans	1.37%	Short Ratio	0.12	Perf Half Y	-
Sales	0.00M	P/B	4.83	EPS next Y	9.62%	ROA	-21.74%	Short Interest	0.03M	Perf YTD	-14.33%
Book/sh	1.91	P/C	36.17	EPS next 5Y	15.35%	ROE	-23.61%	52W High	11.23 -17.99%	Perf Year	-
Cash/sh	0.25	P/FCF	-	EPS past 3/5Y	-180.07% -	ROIC	-14.04%	52W Low	8.33 10.56%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.13% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	23.72%	Oper. Margin	-	ATR (14)	0.70	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.58	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	41.58	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.58	EPS Q/Q	34.54%	SMA20	-2.61%	Beta	-	Target Price	22.70
Payout	-	Debt/Eq	0.09	Sales Q/Q	-	SMA50	-3.80%	Rel Volume	0.36	Prev Close	10.00
Employees	18	LT Debt/Eq	0.08	Earnings	-	SMA200	-3.80%	Avg Volume	258.60K	Price	9.21
IPO	Apr 30, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	75,051	Change	-7.90%

May-26-26 08:43AM	Silver Bow Mining Receives Authorization to Proceed from Montana DEQ for Expanded Rainbow Block Exploration Program (Newsfile Corp.)
May-12-26 08:38AM	Silver Bow Mining Corp. Initiates Chief Joseph Portal and Underground Decline Rehabilitation (Newsfile Corp.)
May-08-26 08:55AM	NYSE Content Update: HawkEye 360 Soars 31% in Trading Debut (PR Newswire)
May-07-26 04:35PM	Silver Bow Mining Corp. Leadership to Ring the Opening Bell at the NYSE (Newsfile Corp.)
08:45AM	Silver Bow Mining Corp. Announces Executive Appointments of Kevin Shiell and Doug Stiles (Newsfile Corp.)
06:43PM	Loading…
May-04-26 06:43PM	Silver Bow Mining Corp. Announces Commencement of Surface Drilling at Butte Project (Newsfile Corp.) -8.95%
May-01-26 12:10PM	Silver Bow Mining Corp. Closes Its Upsized Initial Public Offering (Newsfile Corp.)

Silver Bow Mining Corp. is engaged in the acquisition, exploration, and development of mineral resource properties in the United States. The firm currently has the Rainbow Block project located in Butte, Montana which offers resources such as silver, zinc, gold, and lead. The company was founded on August 31, 2020 and is headquartered in Butte, MT.

ChairmanMr. Charles Travis Naugle

Chief Financial OfficerMr. Wade Newton Black M.B.A.

Vice President of ExplorationDr. Phillip Nickerson

Chief Operating OfficerMr. Kevin G. Shiell

Chief Accounting OfficerMr. Peter Burroughs

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Black Wade Newton	Chief Financial Officer	May 29 '26	Buy	9.69	2,500	24,231	10,000	Jun 01 12:03 PM
Black Wade Newton	Chief Financial Officer	May 26 '26	Buy	8.50	5,000	42,502	7,500	May 27 11:12 AM
Black Wade Newton	Chief Financial Officer	May 18 '26	Buy	8.83	2,500	22,075	2,500	May 19 12:57 PM
Naugle Charles Travis	Chief Executive Officer	May 18 '26	Buy	8.83	2,500	22,075	107,500	May 18 07:26 PM
Naugle Charles Travis	Chief Executive Officer	Apr 30 '26	Buy	9.88	5,000	49,409	105,000	May 01 06:13 PM
Black Wade Newton	Chief Financial Officer	Apr 30 '26	Buy	10.75	500	5,375	25,000	Apr 30 02:50 PM

Open in Screener

CMMB

Chemomab Therapeutics Ltd ADR

Jun 01 • 02:35PM ET

1.91

-0.09 -4.50 %

Healthcare • Biotechnology • Israel • Nano • NASD

CMMB Chemomab Therapeutics Ltd ADR daily Stock Chart

Peers: COCP CVKD HCWB HIND INAB LEXX MTVA NCEL OSRH XCUR

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	4.53%	Shs Outstand	7.20M	Perf Week	-5.45%
Market Cap	13.75M	Forward P/E	-	EPS next Y	-0.03	Insider Trans	0.00%	Shs Float	6.87M	Perf Month	29.93%
Enterprise Value	5.71M	PEG	-	EPS next Q	0.00	Inst Own	4.88%	Short Float	0.58%	Perf Quarter	-2.55%
Income	-7.50M	P/S	-	EPS this Y	-11.11%	Inst Trans	-0.50%	Short Ratio	0.87	Perf Half Y	-24.51%
Sales	0.00M	P/B	1.29	EPS next Y	-50.00%	ROA	-60.93%	Short Interest	0.04M	Perf YTD	15.76%
Book/sh	1.49	P/C	1.71	EPS next 5Y	-	ROE	-71.16%	52W High	5.52 -65.40%	Perf Year	-63.83%
Cash/sh	1.12	P/FCF	-	EPS past 3/5Y	47.24% 43.73%	ROIC	-70.15%	52W Low	1.35 41.48%	Perf 3Y	-70.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.28% 8.39%	Perf 5Y	-97.20%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	63.33%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.31	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.31	EPS Q/Q	61.72%	SMA20	6.61%	Beta	0.62	Target Price	15.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	13.31%	Rel Volume	2.89	Prev Close	2.00
Employees	12	LT Debt/Eq	0.00	Earnings	May 14 BMO	SMA200	-14.59%	Avg Volume	45.68K	Price	1.91
IPO	Feb 12, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	104,941	Change	-4.50%

Date	Action	Analyst	Rating Change	Price Target Change
May-13-24	Initiated	Maxim Group	Buy	$4
May-06-24	Upgrade	Oppenheimer	Perform → Outperform	$6
Dec-19-23	Resumed	ROTH MKM	Buy	$7

May-14-26 08:00AM	Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-19-26 08:00AM	Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Feb-17-26 08:00AM	Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Dec-02-25 08:00AM	Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology (GlobeNewswire)
Nov-24-25 08:00AM	Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit (GlobeNewswire)
08:00AM	Loading…
Nov-20-25 08:00AM	Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) -10.00%
Nov-06-25 08:00AM	Chemomab Announces Multiple Presentations at AASLD The Liver Meeting 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis (GlobeNewswire)
Oct-23-25 10:27AM	ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition (Zacks) -5.83%
10:00AM	Best Momentum Stocks to Buy for Oct. 23 (Zacks)
07:05AM	New Strong Buy Stocks for Oct. 23: MQ, GES and More (Zacks)
Oct-22-25 10:18AM	SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study (Zacks) -8.85%
Oct-21-25 09:34AM	Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis (Zacks)
09:30AM	NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients (Zacks)
Oct-17-25 11:52AM	ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up (Zacks)
11:44AM	NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs (Zacks)
11:14AM	Loading…
Oct-16-25 11:14AM	Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan (Zacks)
Oct-15-25 11:35AM	CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer (Zacks)
11:31AM	RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy (Zacks)
Oct-14-25 11:24AM	TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals (Zacks)
Oct-13-25 01:06PM	Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain (Zacks)
10:15AM	TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder (Zacks)
Oct-10-25 12:21PM	CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza (Zacks)
10:27AM	OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data (Zacks)
Oct-08-25 11:18AM	KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure (Zacks)
11:15AM	AstraZeneca's Baxdrostat Meets Goal in Resistant Hypertension Study (Zacks)
Oct-07-25 11:56AM	MRK Expands Tulisokibart Program in Three New Inflammatory Diseases (Zacks) +21.43%
Aug-21-25 08:00AM	Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-14-25 08:00AM	Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) -6.34%
Jun-30-25 08:00AM	Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live'25 (GlobeNewswire)
Jun-11-25 08:00AM	Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis (GlobeNewswire) -7.48%
11:52AM	Loading…
Jun-06-25 11:52AM	KURA Stock Rises More Than 15% This Past Week: Here's Why (Zacks)
11:35AM	TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy (Zacks)
Jun-03-25 08:00AM	Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis (GlobeNewswire)
Jun-02-25 10:53AM	MRK's ADC Drug Combo Shows Antitumor Activity in Lymphoma Study (Zacks)
May-30-25 10:20AM	NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study (Zacks)
May-29-25 10:50AM	CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer (Zacks)
May-28-25 11:09AM	RCKT Stock Tanks on Patient Death in Danon Disease Study (Zacks)
11:07AM	TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate (Zacks)
May-15-25 08:00AM	Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire) +6.61%
May-05-25 08:00AM	Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025 (GlobeNewswire) -6.34%
May-01-25 12:15PM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
Apr-28-25 08:00AM	Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug's Impact in Primary Sclerosing Cholangitis and Related Diseases (GlobeNewswire)
Apr-21-25 08:00AM	Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences (GlobeNewswire)
Apr-15-25 08:00AM	Chemomab Announces New Medical and Clinical Appointments (GlobeNewswire)
Mar-27-25 08:30AM	Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers (GlobeNewswire) -5.17%
Mar-06-25 08:00AM	New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab's Nebokitug in Systemic Sclerosis (GlobeNewswire) +5.71%
Mar-03-25 08:00AM	Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update (GlobeNewswire) -10.12%
Feb-19-25 07:00AM	Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis (GlobeNewswire)
Feb-03-25 07:00AM	Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Dec-03-24 07:00AM	Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit (GlobeNewswire)
Nov-19-24 07:00AM	Oral Presentation at AASLD The Liver Meeting 2024 Highlights Broad Clinical Activity of Chemomab's CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis (GlobeNewswire)
Nov-14-24 07:00AM	Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-30-24 07:00AM	Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update (GlobeNewswire)
Oct-15-24 07:00AM	Chemomab Therapeutics Announces Late-Breaking Oral Presentation of CM-101 Phase 2 Results in Primary Sclerosing Cholangitis at AASLD The Liver Meeting 2024 (GlobeNewswire) +9.17%
Oct-01-24 07:00AM	Chemomab Therapeutics to Present at October 2024 Investor Conferences (GlobeNewswire)
Aug-28-24 07:00AM	Chemomab Therapeutics to Present at September 2024 Investor Conferences (GlobeNewswire) +12.73%
Aug-21-24 07:00AM	Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 07:00AM	Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update (GlobeNewswire)
Jul-30-24 09:00AM	Chemomab Therapeutics Announces Closing of $10 Million Private Placement (GlobeNewswire)
Jul-26-24 07:00AM	Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +6.72%
Jul-25-24 07:38AM	Chemomab Therapeutics Announces $10 Million Private Placement (GlobeNewswire) -16.20%
07:00AM	Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis (GlobeNewswire)
Jun-27-24 12:00PM	Chemomab Therapeutics (CMMB) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-18-24 07:00AM	Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis (GlobeNewswire) +11.54%
Jun-06-24 07:00AM	Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference (GlobeNewswire) -11.64%
May-17-24 07:00AM	Chemomab Therapeutics to Participate in Upcoming Scientific Conferences (GlobeNewswire)
May-10-24 09:55AM	Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy? (Zacks)
May-09-24 11:57AM	CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q1 2024 (InvestorPlace) +11.72%
07:00AM	Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-08-24 07:00AM	Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire) -18.42%
May-02-24 07:00AM	Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference (GlobeNewswire)
Apr-24-24 07:00AM	Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update (GlobeNewswire)
Apr-18-24 07:00AM	Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis (GlobeNewswire) +18.64%
Apr-02-24 07:00AM	Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024 (GlobeNewswire)
Mar-25-24 07:06AM	Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis (GlobeNewswire) -5.60%
Mar-07-24 12:53PM	CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023 (InvestorPlace) +12.63%
07:00AM	Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update (PR Newswire)
Mar-05-24 07:00AM	Chemomab Therapeutics to Participate in Leerink Global BioPharma Conference (PR Newswire)
Feb-20-24 07:00AM	Chemomab Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases (PR Newswire) +6.37%
Feb-14-24 07:00AM	Chemomab Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update (PR Newswire)
Feb-05-24 07:00AM	Chemomab Therapeutics to Participate in Upcoming Investor Conferences (PR Newswire) +6.56%
Jan-30-24 07:00AM	Chemomab Therapeutics Announces New Publication Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis (PR Newswire) +7.41%
Jan-03-24 07:00AM	Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial and Moves Up Expected Topline Readout to Midyear 2024 (PR Newswire)
Nov-16-23 07:00AM	Chemomab Presentation at ACR Convergence 2023 Provides Further Support for Key Role of Its CCL24 Target in the Pathogenesis of Systemic Sclerosis (PR Newswire) -19.22%
Nov-15-23 07:00AM	Chemomab Therapeutics Receives FDA Fast Track Designation for CM-101 for the Treatment of Primary Sclerosing Cholangitis (PR Newswire) +33.93%
Nov-13-23 08:00AM	Chemomab Presents New Clinical Data Supporting CM-101's Anti-Fibrotic/Anti-Inflammatory Activity in Patients with Liver Fibrosis and New Data Highlighting Unique Association of Its CCL24 Target with Key PSC Pathways at AASLD's The Liver Meeting 2023 (PR Newswire) -6.78%
Nov-09-23 08:00AM	Chemomab Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire) -6.10%
Nov-06-23 04:15PM	Chemomab Therapeutics Discloses Receipt of Nasdaq Notice Regarding Minimum Bid Price Requirement (PR Newswire) -6.78% -6.21%
Oct-30-23 07:00AM	Chemomab Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update (PR Newswire) -7.15%
Oct-26-23 07:00AM	Chemomab Therapeutics to Present at Upcoming Scientific Conferences (PR Newswire)
Sep-28-23 07:00AM	Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference (PR Newswire)
Aug-29-23 07:00AM	Chemomab Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire)
Aug-14-23 08:00AM	Chemomab Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Corporate Update (PR Newswire)
Jun-28-23 07:00AM	Chemomab Therapeutics Announces Publication in JCI Insight Demonstrating Key Role of CCL24 in Primary Sclerosing Cholangitis (PR Newswire) -5.37%
Jun-26-23 07:00AM	Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023 (PR Newswire) +28.00%
Jun-21-23 07:00AM	Chemomab Therapeutics Reports Positive Data from Secondary Analysis of Phase 2a Liver Fibrosis Trial in NASH Patients at EASL 2023 (PR Newswire) -13.22%
Jun-05-23 07:00AM	Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update (PR Newswire)
Jun-02-23 09:00AM	Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis (PR Newswire) +8.12%
May-24-23 07:00AM	Chemomab Therapeutics to Participate in Upcoming Scientific Conferences (PR Newswire)
May-11-23 06:00AM	Chemomab Therapeutics Announces First Quarter 2023 Financial Results and Provides a Corporate Update (PR Newswire)

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Co-FounderDr. Adi Mor George Ph.D.

M.B.A.Ms. Sigal Fattal CPA

Chief Development OfficerMr. Jack Lawler

M.D.Dr. David M. Weiner M.B.A.

BFS

Saul Centers Inc

BZUN

Baozun Inc ADR

MTDR

Matador Resources Co

SBMT

Silver Bow Mining Corp

CMMB

Chemomab Therapeutics Ltd ADR

Upgrade your Finviz experience